Chronic Leukemia
Most recent articles
Association between thymoma and persistent hypothermia: a case report
Introduction The thymus is a small anterosuperior mediastinal organ involved in the processing and maturation of T lymphocytes. The thymus gland...
IRIS at Five Years Still Changing the Face of Long-term Chronic Myeloid Leukemia Therapy
The standard therapeutic options that were available before the imatinib era were recombinant interferon-alpha, chemotherapy with hydroxyurea,...
Nilotinib in Chronic-phase Chronic Myeloid Leukemia
CML is a monoclonal stem cell disorder accounting for approximately 20% of adult leukemias.1 The median age at first diagnosis is 60 years and the...
Long-term Chronic Myeloid Leukaemia Therapy
Clinically, CML progresses through three distinct phases of increasing refractoriness to therapy: chronic phase (median duration three to four years;...
Alemtuzumab as First-line Treatment for Progressive B-cell Chronic Lymphocytic Leukaemia
This latter observation is largely due to the ability to successfully re-treat relapsed patients. However, patients who become refractory to...
